LifeStance (LFST) director Justice Thurman files baseline Form 3 with no trades

Rhea-AI Filing Summary

LifeStance Health Group, Inc. director Justice Thurman has filed an initial Form 3 ownership report. The filing does not list any buy, sell, or other insider transactions or derivative positions, indicating that this is a baseline disclosure of status as a reporting person rather than a trading event.

Key Terms

Form 3, reporting person, director

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

""reportingPersons": [ { "name": "Justice Thurman""

director financial

""is_director": 1"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/07/2026 - 07:26 PM Accepted by SEC EDGAR 07/07/2026 - 07:25 PM Learn about SEC filing dates

FAQ

What does Justice Thurman’s Form 3 filing for LFST show?

The Form 3 shows that Justice Thurman is a director of LifeStance Health Group, Inc. It serves as an initial ownership report and, in this case, does not list any insider transactions or derivative positions.

Did Justice Thurman buy or sell LifeStance (LFST) shares in this Form 3?

No transactions are reported for Justice Thurman in this Form 3. The transaction summary shows zero buys, sells, exercises, gifts, tax withholdings, or restructurings, indicating no trading activity is disclosed in this filing.

What is the role of Justice Thurman at LifeStance Health Group, Inc. (LFST)?

Justice Thurman is identified as a director of LifeStance Health Group, Inc. The Form 3 flags the reporting person as a director and not an officer or ten percent owner, establishing their status under insider reporting rules.

Does the LifeStance (LFST) Form 3 include any derivative holdings?

The Form 3 derivative summary is empty for Justice Thurman. It shows zero derivative transactions and no remaining derivative positions, indicating no options or similar instruments are reported in this initial statement.

What does a neutral net buy/sell direction mean in this LFST Form 3?

A neutral net buy/sell direction means the filing reports no net change in share ownership through transactions. For Justice Thurman’s Form 3, all transaction counts and share amounts are zero, so there is no buying or selling activity recorded.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Justice Thurman

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE ARIZONA 85251

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/02/2026

3. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Ryan Pardo, Attorney-in-Fact	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)